'Exclusion criteria' presentation slideshows

CAROTID ARTERY STENTING WITH EMBOLI PROTECTION

CAROTID ARTERY STENTING WITH EMBOLI PROTECTION. PMA # P030047. Cordis Presentation Sidney A. Cohen, M.D., Ph.D. Group Director, Clinical Research. REQUESTED INDICATION .

2.21k views • 131 slides

Pharmacologic Treatment of Obesity: What is the skinny on diet pills?

Pharmacologic Treatment of Obesity: What is the skinny on diet pills? Stephanie E. Freeman, MD Department of Internal Medicine Resident Grand Rounds May 6, 2003 Patient 1 40 year old female, 400+ pounds PMH: CHF, HTN, OSA

1.24k views • 45 slides

Myocardial Infarction Angioplasty The Middlesbrough Experience

Myocardial Infarction Angioplasty The Middlesbrough Experience. Rob Wright James Cook University Hospital. Acknowledgements. Mark de Belder Jim Hall Alun Harcombe Andrew Sutton Bob Morley and the Audit Team Cath Lab Team CCU. SCH Original AMI PCI Protocol.

558 views • 38 slides

Acquired Resistance to EGFR TKIs: What Is It and How Do We Treat?

Acquired Resistance to EGFR TKIs: What Is It and How Do We Treat?. Vincent A Miller, MD Thoracic Oncology Service Memorial Sloan-Kettering Cancer Center. Disclosure Slide. Background. Patients with CML and GIST have a high rate of response to treatment with imatinib.

1.3k views • 37 slides

EPIDURAL magnesium for post operative analgesia.

EPIDURAL magnesium for post operative analgesia. CO AUTHORS: Prof.& HOD Dr.I.CHANDRASEKARAN MD, DA Prof . Dr.GANESH PRABHU MD, DA ., Asst . Prof.Dr . SIVAPRASATH MD ., INSTITUTE OF ANAESTHESIOLOGY MADURAI MEDICAL COLLEGE . Dr. ANJU PADMALAYAN PG . AIM.

869 views • 35 slides

CILON-T Late Breaking Trial : Randomized prospective trial of dual vs. triple antiplatelet therapy after DES implantatio

CILON-T Late Breaking Trial : Randomized prospective trial of dual vs. triple antiplatelet therapy after DES implantation . ACC & i2 summit, March 15th 2010, Atlanta, Georgia. Hyo-Soo Kim, MD, PhD Seoul National University Hospital Seoul, Korea . Nothing to disclose . CILON-T trial .

535 views • 29 slides

USE OF LABETALOL FOR ATTENUATION OF HYPERTENSIVE RESPONSE TO ENDOTRACHEAL INTUBATION IN PREECLAMPSIA

CO AUTHORS PROF. DR.I.CHANDRASEKARAN MDDA PROF. DR S.P.MEENAKSHISUNDARAM MDDA ASST PROF. DR.G.VIJAYA MD AUTHOR DR.H.VIJAYALAKSHMI MD PG INSTITUTE OF ANAESTHESIOLOGY MADURAI MEDICAL COLLEGE.

892 views • 24 slides

HEART TRANSPLANTATION

HEART TRANSPLANTATION. MARTIN SUSSMAN MILPARK HOSPITAL. ISSUES. Improvements in survival with medical therapy impacted on old indications for HT. Remain survival and QOL benefits for HF pts despite this Exercise testing strongly recommended, not routinely performed in JHB Peak VO2 < 12.

509 views • 23 slides

434 views • 18 slides

CT Guided Ozonotherapy with Foraminal Approach for Cervical Herniated Discs:6 Months Follow- Up of 50 Patients

508 views • 16 slides

499 views • 16 slides

F. Zijlstra, MD PhD Thoraxcenter University Medical Center Groningen, The Netherlands

Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS) Mortality and reinfarction at 1 year. F. Zijlstra, MD PhD Thoraxcenter University Medical Center Groningen, The Netherlands. TAPAS: Background.

296 views • 15 slides

Endothelial Dystrophy Association with Hyperopia

543 views • 10 slides

CPT and Disclosure: Connecting Critical Processes

CPT and Disclosure: Connecting Critical Processes. November 2018. The Information Flow Challenge.

342 views • 10 slides

DEDICATION

DEDICATION. DEDICATION. Presented at the American College of Cardiology Annual Scientific Session March, 2007 Presented by Dr. Leif Thuesen. DEDICATION : Background.

296 views • 8 slides

Intraocular Pressure After Phacoemulsification in Psuedoexfoliation Patients

Intraocular Pressure After Phacoemulsification in Psuedoexfoliation Patients. Mai Pham MD, Sarosh Janjua MD, Jannet Ung MD, Sandra Cremers MD FACS Massachusetts Eye and Ear Infirmary Harvard Medical School. Purpose.

284 views • 7 slides

Chapter 19

289 views • 6 slides

TRANSPORT2 - Eligibility -

TRANSPORT2 - Eligibility -. Gottfried Schlaug MD PhD Beth Israel Deaconess Medical Center and Harvard Medical School & Wayne Feng MD MS Medical University of South Carolina. Inclusion Criteria. Each subject must meet all of the following criteria to participate in this study:

183 views • 4 slides

SmartCare (objective 3.1)

SmartCare (objective 3.1). Builds on: the success of previous AAL EU projects (DREAMING, CommonWell ) the expertise of organisations which have successfully managed previous Pilots A ( epSOS , RENEWING HEALTH) in the health field

178 views • 3 slides

MetroHealth Medical Center Outpatient Treatment of Venous Thromboembolism with Low-Molecular-Weight Heparin Catalyst In

MetroHealth Medical Center Outpatient Treatment of Venous Thromboembolism with Low-Molecular-Weight Heparin Catalyst Initiative Improvement Project. Improvement Cycles Required Development of a Patient Education Program Development of a standardized follow-up system in the outpatient setting

223 views • 1 slides